Related Experiment Video
Updated: Oct 15, 2025

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Expression of Oncogenic Molecules in Pediatric Ulcerative Colitis
Nobuyasu Arai1, Takahiro Kudo2, Kazuhide Tokita2
1Department of Pediatric and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan, n-arai@juntendo.ac.jp.
Pediatric ulcerative colitis (UC) patients show increased expression of cancer-related genes, PIM2 and SPI1. This suggests chronic inflammation in childhood UC may elevate colorectal cancer risk.
Area of Science:
- Gastroenterology
- Pediatric Oncology
- Molecular Biology
Background:
- Long-term ulcerative colitis (UC) increases colorectal cancer risk in adults.
- This association lacks genetic analysis in pediatric UC.
- Investigating cancer-related gene expression in pediatric UC is crucial.
Purpose of the Study:
- To examine cancer-related gene expression in pediatric UC patients.
- To assess the association between gene expression and colorectal cancer risk in children with UC.
Main Methods:
- Microarray analysis of rectal mucosa biopsy specimens from pediatric UC patients (active and remission phases) and controls.
- Validation using real-time polymerase chain reaction (PCR) and immunohistochemical staining.
- Analysis of cancer-related genes including PIM2, SPI1, TP53, and APC.
Main Results:
- Microarray identified higher PIM2 and SPI1 expression in active UC.
- Real-time PCR confirmed elevated PIM2 and SPI1, and reduced TP53 and APC in active UC.
- Immunohistochemistry supported PCR findings for all analyzed genes.
Conclusions:
- Pediatric UC patients exhibit significantly altered expression of cancer-related genes compared to controls.
- Gastrointestinal inflammation in childhood-onset UC elevates cancer-related gene expression.
- Chronic inflammation in pediatric UC may increase future colorectal cancer risk.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

